Jabrane Karkouri1,2,3, Jill Slade4, Helene Ratiney1, Sylvain Grange1, Anne Tonson4, Pierre Croisille1, and Magalie Viallon1
1Université de Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Lyon, France, Lyon, France, 2SIemens Healthcare SAS, Saint-Denis, France, 3Wolfson Brain Imaging Center, University of Cambridge, Cambridge, United Kingdom, 4Radiology, Michigan state university, East Lansing, MI, United States
Synopsis
Obliterative arterial disease of the lower limbs is a
disease that obstructs lower extremities arteries, resulting in reduced lower
limb perfusion and possibly mitochondrial dysfunction. Mitochondrial function
of the calf assessed via 31P MRS at moderate and low exercise intensities
before and after revascularization and phase contrast angiography of the
posterior tibial artery enabled the assessment of vascular and mitochondrial
contributions of the patients.
Introduction
Obliterative arterial disease of the lower limbs also known as peripheral
arterial occlusive disease (PAOD) is defined as partial or total obstruction of
one, or more, lower extremity arteries most often of atherosclerotic origin [1,2]. It
is a common pathology whose five-year mortality of a patient with PAOD is about
30%, mainly of cardiovascular origin. In addition, most of the literature
suggests that lower extremity mitochondrial function is severely reduced in PAOD. The main objective is to study skeletal
muscle mitochondrial function by 31P spectroscopy (τPCr) before and after
revascularization in patients with PAOD using an exercise paradigm that approaches
the ischemic stress stage and using an alternative exercise paradigm that is
well below ischemic stress[3,4].
This approach allow insight into the relative contribution of the vascular and
mitochondrial components to the degradation of muscle function in PAOD. The
overall hypothesis was that slowed τPCr in PAOD is the result of reduced
skeletal muscle perfusion. Successful revascularization should be accompanied
by an immediate improvement of the τPCr in the absence of mitochondriopathy. On
the other hand, in the case of mitochondrial disease, the τPCr should remain
altered in early post-revascularization and despite the lifting of the vascular
factor.Methods
Experimental protocol
Four patients (male, age=60±6
yrs old, mean±SD) were measured
before and after revascularization. Each patient was supine on the MR bed of the scanner, with a
surface coil 31P/1H Tx/Rx under the calf muscle.
For dynamic measurements, an
MR compatible ergometer was used during isometric plantar flexion. MR scans were performed using a non-localized,
MR-FID sequence with saturation bands done with adiabatic pulses[5].
Maximum Voluntary Contraction (MVC) force were
performed for 1-2 s. Prior localization was done with a dixon sequence (FA 9deg , TR 4.1ms, TE 1.4ms, matrix size 118×192 , FOV 169×206 ). Thus,
resting 31P acquisitions were done with a 90deg FA, TR 30s,10 averages, bandwidth 2500Hz, and saturation bands placed on anterior muscles. Then, 2 dynamic protocols were performed with TR 4s, but with different dynamic
resolution times (time between two exercises), see figure 1. Thus, a moderate
intensity exercise protocol, expected to approach the ischemic stage as well as
a low intensity gated exercise protocol that would be well above the ischemic
limit were performed by each subject before and after revascularization. A
total of 30 contractions were performed in the moderate protocol at a rate of
0.25 Hz and a total of 15 contractions were performed in the gated protocol at
a rate of 0.05 Hz. In addition, resting flow in the posterior tibial artery was
assess with ECG gated phased contrast MR angiography.
Data Processing
Data was processed using CSIAPO software[7] for phasing, MATLAB(The MathWorks)
and the method QUEST(QUantitation based on QUantum ESTimation)[8]. For the
gated protocol, the last 10 contractions cycles were averaged together,
resulting in 10 points during the contraction/recovery cycle. In addition, 10
spectra were averaged over the initial rest. The following formula was used to
estimate τPCr gated:
τ=-Δt/ln[D/(D+Q)],
where D represents the PCr drop to the steady
state (rest PCr–max PCr after steady state is reached), Q is the PCr change in the steady state (max PCr in the steady state–minimum PCr),
and t=time between contractions[6]. pH was determined using the frequency
difference between PCr and Pi as:
pH=pKa1+log((FreqPi−FreqPCr)−pKam)./pKaM−(FreqPi−FreqPCr),
with pKa1=6.75, pKam=3.27,
pKaM=5.69 and FreqPCr and FreqPi the resonant frequencies of PCr and Pi[9].
For blood velocity and flow analyses, velocity was extracted
from each time point across the cardiac cycle. Flow was the product of the vessel
CSA and velocity averaged across the vessel. Data were compared using paired
t-tests to examine differences between exercise protocol and between
measurement times with significance at p<0.05. Results
Figure 2 shows a
sample stack plot of spectra from the moderate exercise protocol and the low
intensity gated protocol; Table 1 reports the MRS results. In general, the PCr
recovery time constant was substantially longer for the moderate compared to
the gated exercise protocol before surgery (τ=72.2s vs. 34.5s, respectively,
p=0.012). Following surgery, there was a 33% improvement of the τPCr for the moderate protocol (p=0.039).
However, there was no significant improvement in τPCr for the gated protocol.
Blood flow parameters
are reported in Table 1. The arterial waveforms are shown in Figure 3. The
waveforms in 3 cases are characterized as monophasic. Following
revascularization, there was an apparent increase in peak blood velocity that
approached significance. This was particularly the case for
Subj01 and Subj03 who adopted a biphasic arterial waveform following
revascularization. Discussion
The results primarily
indicate that blood flow is a large determinant of the measured PCr time
constant under standard exercise conditions. This is demonstrated both when
comparing the moderate to the low intensity protocol and when examining the
moderate exercise PCr time constant post-surgery. These results encourage the
quantification of blood flow when assessing mitochondrial function in
conditions of compromised flow. Alternatively, a “gated” low intensity protocol
may be utilized to independently assess mitochondrial function in conditions of
compromised blood flow, oxygen delivery, or oxygen consumption. Acknowledgements
This work has been supported by
Siemens Healthineers and the LABEX PRIMES (ANR-11-LABX-0063), program ”Investissements
d’Avenir” (ANR-11-IDEX-0007) and carried out within the framework of France Life Imaging (ANR-11-INBS-0006).References
1. Eric P Brass, William R Hiatt, and Simon
Green. “Skeletal muscle metabolic changes in peripheral arterial disease
contribute to exercise intolerance: a point-counterpoint discussion”. In:
Vascular medicine 9.4 (2004), pp. 293–301
2. Eric P Brass and William R Hiatt. “Acquired
skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial
disease”. In: Vascular Medicine 5.1 (2000), pp. 55–59
3. David C
Isbell, Stuart S Berr, Alicia Y Toledano, et al. “Delayed calf muscle
phosphocreatine recovery after exercise identifies peripheral arterial
disease”. In: Journal of the American College of Cardiology 47.11 (2006), pp.
2289–2295
4. PIPINOS, Iraklis I.,
SHEPARD, Alexander D., ANAGNOSTOPOULOS, Petros V., et al. Phosphorus 31 nuclear magnetic resonance spectroscopy
suggests a mitochondrial defect in claudicating skeletal muscle. Journal of vascular surgery, 2000, vol. 31, no
5, p. 944-952
5. LUO, Y., DE GRAAF, R. A., DELABARRE,
L., et al. BISTRO: an outer‐volume suppression method that tolerates RF field
inhomogeneity. Magnetic
Resonance in Medicine: An Official Journal of the International Society for
Magnetic Resonance in Medicine, 2001, vol. 45, no 6, p. 1095-1102
6. Jill M Slade,
Theodore F Towse, Mark C DeLano, Robert W Wiseman, and Ronald A Meyer. “A gated
31P NMR method for the estimation of phosphocreatine recovery time and
contractile ATP cost in human muscle”. In: NMR in Biomedicine: An International
Journal Devoted to the Development and Application of Magnetic Resonance In
vivo 19.5 (2006), pp. 573–580
7. Yann Le Fur, François Nicoli, Maxime Guye, et al. “Grid-free interactive and automated data processing
for MR chemical shift imaging data”. In: Magnetic Resonance Materials in
Physics, Biology and Medicine 23.1 (2010), pp. 23–30
8. Helene
Ratiney, Mark J Albers, Herald Rabeson, and John Kurhanewicz. “Semi-parametric
time-domain quantification of HR-MAS data from prostate tissue”. In: NMR in
biomedicine 23.10 (2010), pp. 1146–1157
9.
LANZA, Ian R., BHAGRA, Sumit, NAIR, K.
Sreekumaran, et al. Measurement of human skeletal muscle oxidative
capacity by 31P‐MR spectroscopy: a
cross‐validation with in vitro measurements. Journal of Magnetic
Resonance Imaging, 2011, vol. 34, no 5, p. 1143-1150